How traditional Chinese medicine can prevent recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography?
Bile acid synthesis pathway. In the classical synthetic pathway, Cytochrome P450 Family 7 Subfamily A Member 1 (CYP7A1) is the first step and the major rate-limiting enzyme in the classical pathway catalysing bile acid synthesis, followed by generation of cholic acid (CA) and chenodeoxycholic acid (CDCA) by Cytochrome P450 Family 8 Subfamily B Member 1 (CYP8B1) and Cytochrome P450 Family 27 Subfamily A Member 1 (CYP27A1) enzymes, with the classical pathway accounting for 90% of bile acid synthesis. In the alternative pathway, cholesterol is catalysed by CYP27A1 and CYP78B1 to produce CDCA-based bile acids, and the generated CA and CDCA are then modified by bile acid-CoA synthetase (BACS) and bile acid Coenzyme A: amino acid N-acyltransferase (BAAT), and then enter the intestinal tract along with the bile in the form of conjugated bile acids, and in the intestinal tract by bile salt hydrolase (BSH), Hydroxysteroid dehydrogenase (HSDH) to become deoxycholic acid (DCA), lithocholic acid (LCA), ursodeoxycholic acid (UDCA) and other secondary bile acids, and then eliminated from the body.
Publication
How traditional Chinese medicine can prevent recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography?. (2024) Haoyu Bian, et al. Front Pharmacol. 2024;15:1363071. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CYP7A1 | CYP7A1 | ncbigene_symbol | CYP7A1 | 1581 |
| Homo sapiens | Primates | CYP27A1 | CYP27A1 | ncbigene_symbol | CYP27A1 | 1593 |
| Homo sapiens | Primates | MRP2 | MRP2 | ncbigene_synonym | ABCC2 | 1244 |
| Homo sapiens | Primates | MRP2 | MRP2 | ncbigene_synonym | KLHL1 | 57626 |
| Homo sapiens | Primates | MRP2 | MRP2 | ncbigene_synonym | SYCE1L | 100130958 |
| Homo sapiens | Primates | CYP8B1 | CYP8B1 | ncbigene_symbol | CYP8B1 | 1582 |
| Homo sapiens | Primates | CYP7B1 | CYP7B1 | ncbigene_symbol | CYP7B1 | 9420 |
| Homo sapiens | Primates | BSEP | BSEP | ncbigene_synonym | ABCB11 | 8647 |
| Homo sapiens | Primates | BACS | BACS | ncbigene_synonym | SLC27A5 | 10998 |
| Homo sapiens | Primates | BAAT | BAAT | ncbigene_symbol | BAAT | 570 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | CLTA | 1211 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | GUCY2D | 3000 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | PTPRC | 5788 |
| Homo sapiens | Primates | DCA | DCA | ncbigene_synonym | HLA-DQA2 | 3118 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| CDCA | CDCA | 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid | chebi:16755 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|